Taro Pharmaceutical
TARO
$39.36
Share price
3.50%
Change (1 day)
12.46%
Change (1 year)
Categories
Taro Pharmaceutical (TARO) - Total liabilities
Total liabilities on the balance sheet as of September 2022 : $0.40 B
According to Taro Pharmaceutical's latest financial reports the company's total liabilities are $0.40 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Taro Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2022)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-03-31 | $0.46 B | -34.65% |
| 2021-03-31 | $0.71 B | 207.32% |
| 2020-03-31 | $0.23 B | 3.25% |
| 2019-03-31 | $0.22 B | 0.63% |
| 2018-03-31 | $0.22 B | 3.18% |
| 2017-03-31 | $0.21 B | -13.93% |
| 2016-03-31 | $0.25 B | -21.69% |
| 2015-03-31 | $0.32 B | 21.45% |
| 2014-03-31 | $0.26 B | 22.31% |
| 2013-03-31 | $0.21 B | |
| 2011-12-31 | $0.22 B | 30.74% |
| 2010-12-31 | $0.17 B | -38.64% |
| 2009-12-31 | $0.28 B | -9.29% |
| 2008-12-31 | $0.30 B | -6.43% |
| 2007-12-31 | $0.33 B | -11.95% |
| 2006-12-31 | $0.37 B | 9.58% |
| 2005-12-31 | $0.34 B | 4.3% |
| 2004-12-31 | $0.32 B | 22.67% |
| 2003-12-31 | $0.26 B | 144.1% |
| 2002-12-31 | $0.10 B | 23.61% |
| 2001-12-31 | $88.62 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $110.57 B | 27,474.63% | 🇺🇸 USA |
 Novartis NVS | $60.09 B | 14,887.32% | 🇨🇭 Switzerland |
 Pfizer PFE | $101.28 B | 25,159.17% | 🇺🇸 USA |
 Merck MRK | $63.10 B | 15,636.20% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $58.57 B | 14,506.52% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $35.31 B | 8,706.76% | 🇮🇱 Israel |